OnKure Therapeutics, Inc.
OKUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001637715
In the last 90 days, OnKure Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 75 institutions reported holding it in 13F filings for Q2 2026, worth $159.0M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in OnKure Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- 0 vs. Q2 2022
- Shares held
- 16.5M
- +77.9K (+0.5%) vs. Q2 2022
- Total value
- $55.1M
- +$11.8M (+27.3%) vs. Q2 2022
- New holders
- 4
- 8 more added
- Sold out
- 4
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OKUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $159.0M |
| Q1 2026 | 51 | $113.9M |
| Q4 2025 | 44 | $32.0M |
| Q3 2025 | 42 | $28.1M |
| Q2 2025 | 49 | $25.8M |
| Q1 2025 | 47 | $50.1M |
| Q4 2024 | 51 | $99.2M |
| Q3 2024 | 51 | $49.0M |
| Q2 2024 | 66 | $41.3M |
| Q1 2024 | 62 | $45.4M |
| Q4 2023 | 68 | $40.4M |
| Q3 2023 | 58 | $208.3M |
| Q2 2023 | 52 | $168.9M |
| Q1 2023 | 35 | $102.0M |
| Q4 2022 | 32 | $38.4M |
| Q3 2022 | 33 | $55.1M |
| Q2 2022 | 33 | $43.3M |
| Q1 2022 | 41 | $50.8M |
| Q4 2021 | 39 | $148.9M |
| Q3 2021 | 38 | $136.7M |
| Q2 2021 | 38 | $170.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding OnKure Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 4,786,921 | $16.0M | 0.80% | 00.0% | Unchanged |
| Novo Holdings A/S | 3,430,377 | $11.5M | 0.55% | 00.0% | Unchanged |
| RiverVest Venture Management LLC | 2,409,220 | $8.07M | 9.37% | 00.0% | Unchanged |
| Abingworth LLP | 2,073,957 | $6.95M | 2.38% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 1,143,185 | $3.83M | 0.10% | 00.0% | Unchanged |
| Aisling Capital Management LP | 886,075 | $2.97M | 1.97% | 00.0% | Unchanged |
| Franklin Resources Inc | 407,605 | $1.36M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 318,814 | $1.07M | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 155,819 | $521.0K | 0.26% | −29,778−16.0% | Reduced |
| Citadel Advisors LLC | 146,148 | $490.0K | 0.00% | −26,437−15.3% | Reduced |
| Geode Capital Management, LLC | 88,503 | $296.0K | 0.00% | +35,145+65.9% | Added |
| Barclays PLC | 71,930 | $241.0K | 0.00% | +17,984+33.3% | Added |
| MAI Capital Management | 63,210 | $212.0K | 0.00% | +63,210 | New |
| UBS Group AG | 57,597 | $193.0K | 0.00% | +3,047+5.6% | Added |
| Bridgeway Capital Management, LLC | 45,000 | $151.0K | 0.00% | −25,000−35.7% | Reduced |
| Renaissance Technologies LLC | 43,000 | $144.0K | 0.00% | +20,000+87.0% | Added |
| Morgan Stanley | 39,886 | $134.0K | 0.00% | +19,391+94.6% | Added |
| Ergoteles LLC | 37,640 | $126.0K | 0.00% | −4,760−11.2% | Reduced |
| Millennium Management LLC | 37,430 | $125.0K | 0.00% | −22,256−37.3% | Reduced |
| Federated Hermes, Inc. | 30,000 | $101.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 26,357 | $88.0K | 0.00% | +26,357 | New |
| BlackRock Inc. | 23,803 | $80.0K | 0.00% | +791+3.4% | Added |
| Commonwealth Equity Services, LLC | 22,347 | $74.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 18,415 | $62.0K | 0.00% | +18,415 | New |
| Bank of America Corp | 17,559 | $59.0K | 0.00% | −4,921−21.9% | Reduced |
| State Street Corp | 16,400 | $55.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 15,967 | $53.0K | 0.00% | −1,681−9.5% | Reduced |
| RBF Capital, LLC | 14,536 | $49.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,907 | $40.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 11,063 | $37.0K | 0.00% | +11,063 | New |
| Citigroup Inc | 7,495 | $25.0K | 0.00% | −384−4.9% | Reduced |
| Wells Fargo & Company | 1,262 | $4.00K | 0.00% | +19+1.5% | Added |
| Royal Bank of Canada | 75 | $0 | 0.00% | +60+400.0% | Added |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −20,983−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,289−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −5−100.0% | Sold out |